Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Childhood Traumatic Grief, Post Traumatic Stress, Post Traumatic Stress Disorder, Depressive Symptoms, Behavioral Problems, Child Overall Daily Functioning, Child and Guardian Relationship
Interventions: Trauma-focused Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 7 Years to 13 Years
Enrollment: 1,280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Osteoarthritis, Knee, Knee Osteoarthritis, Patellofemoral Osteoarthritis
Interventions: HYMOVIS plus Physical Exercise Program (PEP), Physical Exercise Program (PEP) alone; Device · Other
Lead sponsor: Fidia Pharma USA Inc.; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 10
States / cities: Tucson, Arizona • Encinitas, California • Los Angeles, California + 5 more

Conditions: Lack of Savings
Interventions: Individual Development Account and financial education; Behavioral
Lead sponsor: Urban Institute; Other
Eligibility: 18 Years and older
Enrollment: 808 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 2
States / cities: Los Angeles, California • Albuquerque, New Mexico

Conditions: Colitis, Ulcerative
Interventions: Vedolizumab, Adalimumab placebo, Adalimumab, Vedolizumab placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 771 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 77
States / cities: Mobile, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 70 more

Conditions: Hepatitis C
Interventions: Sofosbuvir, PEG, RBV; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 527 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 67
States / cities: Birmingham, Alabama • Montgomery, Alabama • Bakersfield, California + 55 more

Conditions: Obstructive Sleep Apnea
Interventions: DeVilbiss AutoAdjust CPAP with revised algorithm; Device
Lead sponsor: DeVilbiss Healthcare LLC; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Newton, Massachusetts

Conditions: Melanoma, Malignant Melanoma
Interventions: Patient Educational Materials; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Acromegaly, Nonfunctioning Pituitary Tumor
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Major Depressive Disorder (MDD)
Interventions: Extended-Release Bupropion Hydrochloride; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 23
States / cities: Berkeley, California • Beverly Hills, California • La Mesa, California + 20 more

Conditions: Mild Cognitive Impairment (MCI), Cognitive Dysfunction, Cognitive Disorder, Memory Problems
Interventions: Sabroxy™ (Oroxylum indicum extract), Placebo; Dietary Supplement · Other
Lead sponsor: SF Research Institute, Inc.; Network
Eligibility: 60 Years to 85 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cervical Cancer, Behavior
Interventions: Care Group Cervical Cancer Screening Education Curriculum; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 30 Years to 59 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Drug Safety, Heart; Disease, Activity
Interventions: CARD-024, Drug Carrier; Drug · Other
Lead sponsor: Cardiavent Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Kalamazoo, Michigan

Conditions: Cardiac Implantable Electronic Device Infection, Cardiovascular Infections
Interventions: Force gauge; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Parkinson's Disease
Interventions: Rasagiline, Placebo; Drug
Lead sponsor: University of Florida; Other
Eligibility: 40 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 3
States / cities: Aurora, Colorado • Gainesville, Florida • Cleveland, Ohio

Conditions: Cystic Fibrosis
Interventions: Motivational Interviewing, Cystic Fibrosis Education; Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 16 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Colonic Neoplasms, Colorectal Neoplasms, Colonic Diseases, Gastrointestinal Neoplasms
Interventions: Health communication intervention, Education information; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 50 Years to 75 Years
Enrollment: 486 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Venous Thromboembolism
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Standard of Care; Drug
Lead sponsor: Bayer; Industry
Eligibility: Up to 17 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 23
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 19 more

Conditions: Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer
Interventions: fluorouracil, gemcitabine hydrochloride, triacetyluridine; Drug
Lead sponsor: Wellstat Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 26
States / cities: Birmingham, Alabama • Burbank, California • Duarte, California + 22 more

Conditions: Pain, Fracture
Interventions: Ankle SSB, Ankle OnQ, DR SSB, DR OnQ; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Keratinized Tissue Augmentation Around Dental Implants
Interventions: Augmented Gingival Matrix graft, Free Gingival Graft; Device · Procedure
Lead sponsor: The Forsyth Institute; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Somerville, Massachusetts

Conditions: Nicotine Dependence
Interventions: Motivational Interviewing, Psychoeducation; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
Interventions: creatine monohydrate, placebo; Dietary Supplement · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2017
U.S. locations: 220
States / cities: Mobile, Alabama • Scottsdale, Arizona • Aurora, Colorado + 139 more

Conditions: Dental Caries
Interventions: Sodium iodide; Device
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Recurrent Urinary Tract Infection
Interventions: Periurethral application of estradiol cream, Intravaginal application of estradiol cream; Drug
Lead sponsor: Stephanie Wang Zuo; Other
Eligibility: 18 Years and older · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 4
States / cities: Cranberry Township, Pennsylvania • Erie, Pennsylvania • Pittsburgh, Pennsylvania

Search by objective public record fields.

Randomized Controlled Trial of Trauma-focused CBT in Tanzania and Kenya

2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)

Assets for Independence Evaluation

An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

Phase 3 Study of Sofosbuvir and Ribavirin

Revised Algorithm for Next Generation DeVilbiss Healthcare AutoAdjust Continuous Positive Airway Pressure (CPAP)

Comparison of Video-Based Versus Written Patient Education on Melanoma

Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors

Effects of Antidepressants on Sexual Functioning

A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns

Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal

Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects

Improving Safety of Lead Extraction Procedures by Traction Force Sensing

Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience

Evaluating Strategies to Present Colon Cancer Screening Information

EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Single Shot Versus OnQ Pump in Extremity Fractures

Keratinized Tissue Augmentation Using Augmented Gingival Matrix Compared to Free Gingival Graft Around Implants

Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI

Creatine in Treating Patients With Cancer-Associated Weight Loss

Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay

Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections